No influence of HLA-C mismatch in unrelated non-myeloablative hematopoietic stem cell transplantation

被引：0
|
作者：
Schaffer, M. [1 ]
Remberger, M. [1 ]
Ringden, O. [1 ]
Mattsson, J. [1 ]
机构：
[1] Karolinska Univ Hosp, Karolinska Inst, Div Clin Immunol, Huddinge, Sweden
来源：
TISSUE ANTIGENS | 2007年 / 69卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：517 / 517
页数：1
相关论文
共 50 条
  • [21] A prospective cost analysis of non-myeloablative hematopoietic stem cell transplantation.
    Skedgel, C
    Edwards, JA
    Roy, J
    McNeil, A
    Gulliver, Y
    Duggan, P
    White, D
    Couban, S
    BLOOD, 2005, 106 (11) : 631A - 631A
  • [22] Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Hodgkin's Disease
    Hovgaard, Doris
    Sengelov, Henrik
    Vindelov, Lars
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S197 - S197
  • [23] Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis
    Oyama, Y.
    Barr, W. G.
    Statkute, L.
    Corbridge, T.
    Gonda, E. A.
    Jovanovic, B.
    Testori, A.
    Burt, R. K.
    BONE MARROW TRANSPLANTATION, 2007, 40 (06) : 549 - 555
  • [24] Non-myeloablative stem cell transplantation in adrenoleukodystrophy
    Kapelushnik, J
    Shapira, Y
    Aker, M
    Hershkoviz, E
    Moser, A
    Selavin, S
    Or, R
    BONE MARROW TRANSPLANTATION, 2003, 31 : S51 - S51
  • [25] Therapeutic applications of non-myeloablative hematopoietic stem cell transplantation in malignant disease
    William J. Hogan
    Rainer Storb
    Immunologic Research, 2003, 28 : 1 - 11
  • [26] Non-myeloablative autologous hematopoietic stem cell transplantation for systemic lupus erythematosus
    Statkute, L
    Oyama, Y
    Verda, L
    Barr, WG
    Rosa, R
    Schroeder, J
    Krosnjar, N
    Quigley, K
    Yaung, K
    Villa, M
    Takahashi, MA
    Burt, RK
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 9 - 9
  • [27] Therapeutic applications of non-myeloablative hematopoietic stem cell transplantation in malignant disease
    Hogan, WJ
    Storb, R
    IMMUNOLOGIC RESEARCH, 2003, 28 (01) : 1 - 11
  • [28] No effect of HLA-C mismatch after allogeneic hematopoietic stem cell transplantation with unrelated donors and T-cell depletion in patients with hematological malignancies
    Magalhaes, Isabelle
    Uhlin, Michael
    Schaffer, Marie
    Sundin, Mikael
    Hauzenberger, Dan
    Remberger, Mats
    Mattsson, Jonas
    CLINICAL TRANSPLANTATION, 2017, 31 (08)
  • [29] HLA-C Antigen Mismatch Is Associated with Worse Outcome in Unrelated Donor Peripheral Blood Stem Cell Transplantation
    Woolfrey, Ann
    Klein, John P.
    Haagenson, Michael
    Spellman, Stephen
    Petersdorf, Effie
    Oudshoorn, Machteld
    Gajewski, James
    Hale, Gregory A.
    Horan, John
    Battiwalla, Minoo
    Marino, Susana R.
    Setterholm, Michelle
    Ringden, Olle
    Hurley, Carolyn
    Flomenberg, Neal
    Anasetti, Claudio
    Fernandez-Vina, Marcelo
    Lee, Stephanie J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (06) : 885 - 892
  • [30] Non-myeloablative stem cell transplantation - High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation
    Passweg, JR
    Meyer-Monard, S
    Gregor, M
    Favre, G
    Heim, D
    Ebnoether, M
    Tichelli, A
    Gratwohl, A
    BONE MARROW TRANSPLANTATION, 2002, 30 (05) : 267 - 271
12345